As a complement of our in vitro results, these later data show that EVs produced by NFAT3-expressing low invasive breast cancer cells can inhibit metastases spreading but also tumor growth of an aggressive triple negative breast cancer cell line. Here, NFATC4 is linked to triple-negative breast carcinoma.